Immunotherapy for Addiction Treatment: Sbir/Sttr Initiative
The summary for the Immunotherapy for Addiction Treatment: Sbir/Sttr Initiative grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Immunotherapy for Addiction Treatment: Sbir/Sttr Initiative: This RFA encourages small businesses, or small businesses in collaboration with research institutions, to develop effective methods for the large-scale production and clinical testing of monoclonal antibodies or vaccines as therapeutic agents for drug or nicotine addiction and/or overdose. Because the RFA is focused on the advanced phase development of these therapies, applicants should already have access to a new molecular entity (NME), either for active or passive immunization, which is in the advanced stages of preclinical development and is ready to begin the process for translation into clinical trials (large scale GMP production of the entity, toxicity testing, formulation development, stability testing and clinical evaluation). The small business should be conversant with the requirements for the Investigational New Drug (IND) filing of such an entity and should have access to a clinical site. The clinical site could be a part of the small business, the research institution involved in the project, or a subcontractor site.
|Federal Grant Title:||Immunotherapy for Addiction Treatment: Sbir/Sttr Initiative|
|Federal Agency Name:||National Institutes of Health|
|Grant Categories:||Health Education|
|Type of Opportunity:||Discretionary|
|Funding Opportunity Number:||RFA-DA-03-015|
|Type of Funding:||Grant|
|CFDA Descriptions:||Drug Abuse Research Programs|
|Current Application Deadline:||No deadline provided|
|Original Application Deadline:||Apr 23, 2003|
|Posted Date:||Jan 08, 2003|
|Creation Date:||May 23, 2003|
|Archive Date:||May 23, 2003|
|Total Program Funding:|
|Maximum Federal Grant Award:|
|Minimum Federal Grant Award:|
|Expected Number of Awards:|
|Cost Sharing or Matching:||No|
- Applicants Eligible for this Grant
- State governments County governments City or township governments Special district governments Independent school districts Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education For profit organizations other than small businesses Small businesses Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [email protected] NIH OER Webmaster
- Similar Government Grants
- • Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Data Coordination, An...
- • Targeting Inflammasomes in Substance Abuse and HIV (R01 Clinical Trial Not Allowed)
- • Research Networks for the Study of Recovery Support Services for Persons Treated with Medi...
- • The Rat Opioid Genome Project: Clinical Trials not Allowed (U01- Clinical Trial Not Allowe...
- • The National Drug Abuse Treatment Clinical Trials Network (UG1 Clinical Trial Required)
- • NIDA Phase II Small Business Innovation Research (SBIR [R44]) Competing Renewal Awards
- • Drug Abuse Aspects of Hiv/Aids and Other Infections
- • Epidemiology of Drug Abuse
- More Grants from the National Institutes of Health
- • Ethical Issues in Translational Science Research (R01 Clinical Trial Optional)
- • A Collaborative Network to Optimize Emergency Care of Older Adults with Alzheimers Disease...
- • Innovations to Foster Healthy Longevity in Low-Income Settings (R03 Clinical Trial Not All...
- • HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Instit...
- • National Dental Practice-Based Research Network Clinical Trial or Observational Study Plan...